SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-000368
Filing Date
2018-01-03
Accepted
2018-01-03 08:39:51
Documents
2
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5488
2 EX-24 ex-24.htm EX-24 11367
  Complete submission text file 0001104659-18-000368.txt   18377
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Modig Berndt (Reporting) CIK: 0001643072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 18503429